【主题词】Premiers-Mr. Romanow’s report-drugs-national drug agency-governments-pharmaceutical companies-cost of drugs.”

第十一段主题词与第十段主题词做减法得出的差额决定供选择的45题目主题词为：report, drug costs 在备选答案中找到以该词为主题词的段落，即B。

Directions: In the following text, some sentences have removed. For Questions 41-45, choose the most suitable one from the list A-G to fit into of the numbered blank there are two extra choices, which do not fit in any of the gaps. Mark your answers on ANSWER SHEET1. (2005年真题原文)

Canada’s premiers (the leaders of provincial governments), if they have any breath left after complaining about Ottawa at their late July annual meeting, might spare a moment to do something, to reduce health-care costs.

They’re all groaning about soaring health budgets, the fastest-growing component of which are pharmaceutical costs.

41.

What to do? Both the Romanow commission and the Kirby committee on health care-to say nothing of reports from other experts-recommended the creation of a national drug agency. Instead of each province having its own list of approved drugs, bureaucracy, procedures and limited bargaining power, all would pool resources, work with Ottawa, and create a national institution.

42.

But “national” doesn’t have to mean that. “National” could mean interprovincial-provinces combining efforts to create one body. Either way, one benefit of a “national” organization would be to negotiate better prices, if possible, with drug manufacturers. Instead of having one province-or a series of hospitals within a province-negotiate a price for a given drug on the provincial list, the national agency would negotiate on behalf of all provinces. Rather than, say, Quebec, negotiating on behalf of seven million people, the national agency would negotiate on behalf of 31 million people. Basic economics suggests the greater the potential consumers, the higher the likelihood of a better price.

43.

A small step has been taken in the direction of a national agency with the creation of the Canadian Co-coordinating Office for Health Technology Assessment, funded by Ottawa and the provinces. Under it, a Common Drug Review recommends to provincial lists which new drugs should be included. Predictably and regrettably Quebec refused to join.

上一页  [1] [2] [3] [4] 下一页